Brief: Rigel Pharmaceuticals Enters Amendment To Credit & Security Deal To Extend Maturity For Term Loans
12/04/2024 15:23
April 12 (Reuters) - Rigel Pharmaceuticals Inc RIGL.O :
* RIGEL PHARMACEUTICALS: ON APRIL 11, ENTERED AMENDMENT TO
CREDIT
& SECURITY DEAL OF SEPT 27, 2019 TO EXTEND MATURITY FOR TERM
LOANS TO SEPT 1, 2027
Source text for Eikon: ID:n0001104659-24-046527
Further company coverage: RIGL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rigel Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rigel Pharmaceuticals Q2 revenue rises on strong product demand
Brief: Rigel Pharmaceuticals - Appoints Alison L. Hannah As Executive Vice President And Chief Medical Officer Effective July 1, 2026 - SEC Filing
Brief: Rigel Announces Closing Of Licensing Agreement For Veppanu (Vepdegestrant)